Number of positive COVID-19 tests doubled in one week In the past week from 30 June to 6 July 2021, the number of reported positive COVID-19 tests doubled (+103%) compared to the previous week. This increase was observed in all security regions.
Delta variant on the rise The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.
Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.
Long-term symptoms more common after Lyme disease More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.
Social well-being is improving, compliance with coronavirus measures remains important With the recent easing of the coronavirus measures, social contact and well-being are improving again. Compliance with most measures remains stable for now (such as getting tested by the GGD and avoiding crowds) or is decreasing very gradually.
Breast cancer screening resumes on Bonaire after COVID-19 hiatus Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.
Downward trend remains steady In the past calendar week, there were 32% fewer hospital admissions of patients with COVID-19 compared to the week before. New arrivals in the ICU were also down by 23% compared to the previous week.
RIVM launches study on Long COVID This week RIVM launched the Long COVID study. RIVM is asking people in the Netherlands who test positive for COVID-19 to sign up for the study via LongCOVID.rivm.nl within 7 days after their positive test result.